- In December 2023, Sun Pharmaceutical Industries Ltd. formed a strategic partnership with Aclaris, granting Sun Pharma exclusive rights to utilize deuruxolitinib, a JAK inhibitor, and other isotopic variations of ruxolitinib for the treatment of alopecia areata and androgenetic alopecia
- In July 2023, Cosmo Pharmaceuticals launched phase 3 clinical trials for its topical androgen receptor-blocking medication, Clascoterone Solution
- In June 2023, Dr. Reddy’s Laboratories Ltd. announced the expansion of its generics division in India with the introduction of RgenX, a dedicated segment offering a broader array of affordable products for patients
- In June 2023, Pfizer, Inc. received U.S. FDA approval for Litfulo (ritlecitinib), a treatment for hair loss related to alopecia, which works by blocking inflammatory signals that contribute to increased hair loss
- In March 2023, Sun Pharmaceutical Industries Ltd. finalized the acquisition of Concert Pharmaceuticals, Inc., a company focused on developing innovative treatment options for various forms of alopecia
Frequently Asked Questions
The market is segmented based on Segmentation, By Treatment (Minoxidil, Finasteride, Dutasteride, Oral Antiandrogens, Hair transplant, Low-level Laser Therapy, Counseling, and Others), Gender (Male and Female), Route of Administration (Oral and Topical), End-Users (Clinics, Hospitals, Diagnostic centres, Surgical centres, and others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy) – Industry Trends and Forecast to 2031
.
The Global Androgenetic Alopecia Market size was valued at USD 1.43 USD Billion in 2023.
The Global Androgenetic Alopecia Market is projected to grow at a CAGR of 9.6% during the forecast period of 2024 to 2031.
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
